HM-15421

N/A

Report date: 2025/02/26 11:41:49

Base Information

Drug NameHM-15421
Drug Alias NameLong-acting alpha-galactosidase长效α-半乳糖苷酶HM-15421HM15421GC1134A +[7] 
ClassificationBiologics > Protein drugs > Enzyme
Mechanisms of Actionα-Galactosidase replacements
Targetsα-Galactosidase
Therapy Area/IndicationsFabry Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesArgentinaSouth Korea
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesHanmi Pharmaceutical Co LtdGC Biopharma Corp
China Registration ClassN/A

Develop Information

Active CompaniesHanmi Pharmaceutical Co LtdGC Biopharma Corp
Inactive CompaniesN/A
Active IndicationsFabry Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A